109 related articles for article (PubMed ID: 12111548)
1. The chronobiotic properties of melatonin.
Pévet P; Bothorel B; Slotten H; Saboureau M
Cell Tissue Res; 2002 Jul; 309(1):183-91. PubMed ID: 12111548
[TBL] [Abstract][Full Text] [Related]
2. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
[TBL] [Abstract][Full Text] [Related]
3. Functional MT1 and MT2 melatonin receptors in mammals.
Dubocovich ML; Markowska M
Endocrine; 2005 Jul; 27(2):101-10. PubMed ID: 16217123
[TBL] [Abstract][Full Text] [Related]
4. Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration.
Yehia A; Abulseoud OA
Mol Neurodegener; 2024 Apr; 19(1):36. PubMed ID: 38641847
[TBL] [Abstract][Full Text] [Related]
5. Behavior and physiology in female
Zhu H; Wu M; Mou J; Yang X; Xu Q; Zhang Y; Zhang H; Wang X; Xue H; Xu J; Chen L; Xu L
Front Endocrinol (Lausanne); 2023; 14():1281617. PubMed ID: 38374960
[TBL] [Abstract][Full Text] [Related]
6. Circadian Rhythms Disrupted by Light at Night and Mistimed Food Intake Alter Hormonal Rhythms and Metabolism.
Meléndez-Fernández OH; Liu JA; Nelson RJ
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834801
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson's Disease.
Hu X; Li J; Wang X; Liu H; Wang T; Lin Z; Xiong N
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829955
[TBL] [Abstract][Full Text] [Related]
8. Reversible Control of Reproduction In Queens: Mastering the use of reproductive drugs to manipulate cyclicity.
Romagnoli S; Ferre-Dolcet L
J Feline Med Surg; 2022 Sep; 24(9):853-870. PubMed ID: 36002142
[TBL] [Abstract][Full Text] [Related]
9. Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors.
Elisi GM; Scalvini L; Lodola A; Mor M; Rivara S
J Chem Inf Model; 2022 Jan; 62(1):210-222. PubMed ID: 34932329
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.
Yeganeh Salehpour M; Mollica A; Momtaz S; Sanadgol N; Farzaei MH
Clin Drug Investig; 2019 Jul; 39(7):607-624. PubMed ID: 31054087
[TBL] [Abstract][Full Text] [Related]
11. Melatonin attenuates smoking-induced hyperglycemia via preserving insulin secretion and hepatic glycogen synthesis in rats.
Li T; Ni L; Zhao Z; Liu X; Lai Z; Di X; Xie Z; Song X; Wang X; Zhang R; Liu C
J Pineal Res; 2018 May; 64(4):e12475. PubMed ID: 29437243
[TBL] [Abstract][Full Text] [Related]
12. Clock Genes and Altered Sleep-Wake Rhythms: Their Role in the Development of Psychiatric Disorders.
Charrier A; Olliac B; Roubertoux P; Tordjman S
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468274
[TBL] [Abstract][Full Text] [Related]
13. Chronomedicine and type 2 diabetes: shining some light on melatonin.
Forrestel AC; Miedlich SU; Yurcheshen M; Wittlin SD; Sellix MT
Diabetologia; 2017 May; 60(5):808-822. PubMed ID: 27981356
[TBL] [Abstract][Full Text] [Related]
14. Beneficial Effects of Exogenous Melatonin in Acute Staphylococcus aureus and Escherichia coli Infection-Induced Inflammation and Associated Behavioral Response in Mice After Exposure to Short Photoperiod.
Bishayi B; Adhikary R; Nandi A; Sultana S
Inflammation; 2016 Dec; 39(6):2072-2093. PubMed ID: 27682182
[TBL] [Abstract][Full Text] [Related]
15. Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment.
Masters A; Pandi-Perumal SR; Seixas A; Girardin JL; McFarlane SI
Brain Disord Ther; 2014; 4(1):. PubMed ID: 25705578
[TBL] [Abstract][Full Text] [Related]
16. Ultradian oscillation in expression of four melatonin receptor subtype genes in the pineal gland of the grass puffer, a semilunar-synchronized spawner, under constant darkness.
Ikegami T; Maruyama Y; Doi H; Hattori A; Ando H
Front Neurosci; 2015; 9():9. PubMed ID: 25688184
[TBL] [Abstract][Full Text] [Related]
17. Melatonergic drugs in development.
Carocci A; Catalano A; Sinicropi MS
Clin Pharmacol; 2014; 6():127-37. PubMed ID: 25258560
[TBL] [Abstract][Full Text] [Related]
18. Melatonin treatment results in regression of endometriotic lesions in an ooferectomized rat endometriosis model.
Kocadal NÇ; Attar R; Yıldırım G; Fıçıcıoğlu C; Ozkan F; Yılmaz B; Yesildaglar N
J Turk Ger Gynecol Assoc; 2013; 14(2):81-6. PubMed ID: 24592080
[TBL] [Abstract][Full Text] [Related]
19. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives.
Tordjman S; Najjar I; Bellissant E; Anderson GM; Barburoth M; Cohen D; Jaafari N; Schischmanoff O; Fagard R; Lagdas E; Kermarrec S; Ribardiere S; Botbol M; Fougerou C; Bronsard G; Vernay-Leconte J
Int J Mol Sci; 2013 Oct; 14(10):20508-42. PubMed ID: 24129182
[TBL] [Abstract][Full Text] [Related]
20. Homology models of melatonin receptors: challenges and recent advances.
Pala D; Lodola A; Bedini A; Spadoni G; Rivara S
Int J Mol Sci; 2013 Apr; 14(4):8093-121. PubMed ID: 23584026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
